Published:
Key Takeaways
- Blue Goat Cyber leads medical device cybersecurity compliance following final FDA guidance.
- The company has successfully supported over 150 FDA device clearances.
- Blue Goat Cyber exclusively focuses on medical device cybersecurity and FDA regulations.
- Their comprehensive services cover design to postmarket cybersecurity programs.
- Exclusive Focus: Dedicated exclusively to medical device cybersecurity and FDA compliance.
- Proven Results: Over 150 FDA-cleared medical devices successfully supported through cybersecurity risk management and documentation.
- FDA Regulatory Expertise: Deep experience navigating complex cybersecurity requirements for FDA premarket submissions and global regulations.
- Comprehensive Services: Covering cybersecurity risk assessments, threat modeling, secure design, and postmarket cybersecurity programs.
- Accelerated Compliance: Proven, efficient processes that reduce regulatory delays and speed device approvals.
- FDA Cybersecurity Documentation Development: Complete SBOMs, threat modeling, risk management plans, and secure design documentation aligned with FDA expectations.
- Medical Device Penetration Testing: Simulated attacks and security testing to identify and mitigate device vulnerabilities.
- Secure Development Lifecycle (SDLC) Support: Embedding cybersecurity throughout device design and development.
- Postmarket Cybersecurity Programs: Vulnerability monitoring, coordinated disclosure, and incident response aligned with FDA postmarket expectations.
- Regulatory Gap Analyses: Identifying and remediating cybersecurity risks and documentation gaps to improve compliance readiness.
SCOTTSDALE, AZ, UNITED STATES, July 9, 2025 - Blue Goat Cyber announces its support for manufacturers responding to the FDA's June 27, 2025 guidance, “Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions.”
Editor's note (October 17, 2026): This is a historical July 2025 announcement. The FDA issued a superseding version on February 3, 2026. For current requirements, read the FDA premarket cybersecurity guidance and the current FDA document.
As the leading medical device cybersecurity consulting firm, Blue Goat Cyber reaffirms its position as the trusted partner for manufacturers navigating these complex regulatory demands.
Sources & references
Primary sources cited in this article. Links open in a new tab.
- current FDA document- U.S. FDA